ArticleBMJ (Clinical research ed.)2019

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.

Huseyin Naci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.